192 related articles for article (PubMed ID: 33810393)
21. Alternative Lengthening of Telomeres in the Budding Yeast
Cohn M; Andersson AK; Mateo RQ; Möller MC
G3 (Bethesda); 2019 Oct; 9(10):3345-3358. PubMed ID: 31427453
[TBL] [Abstract][Full Text] [Related]
22. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
23. Alternative lengthening of telomeres in mammalian cells.
Henson JD; Neumann AA; Yeager TR; Reddel RR
Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
[TBL] [Abstract][Full Text] [Related]
24. Telomere Transcripts Target Telomerase in Human Cancer Cells.
Kreilmeier T; Mejri D; Hauck M; Kleiter M; Holzmann K
Genes (Basel); 2016 Aug; 7(8):. PubMed ID: 27537914
[TBL] [Abstract][Full Text] [Related]
25. Alternative Lengthening of Telomeres: DNA Repair Pathways Converge.
Sobinoff AP; Pickett HA
Trends Genet; 2017 Dec; 33(12):921-932. PubMed ID: 28969871
[TBL] [Abstract][Full Text] [Related]
26. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes.
Min J; Wright WE; Shay JW
Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760773
[TBL] [Abstract][Full Text] [Related]
27. Telomeric Double Strand Breaks in G1 Human Cells Facilitate Formation of 5' C-Rich Overhangs and Recruitment of TERRA.
Nelson CB; Alturki TM; Luxton JJ; Taylor LE; Maranon DG; Muraki K; Murnane JP; Bailey SM
Front Genet; 2021; 12():644803. PubMed ID: 33841503
[TBL] [Abstract][Full Text] [Related]
28. The role of recombination in telomere length maintenance.
Royle NJ; Méndez-Bermúdez A; Gravani A; Novo C; Foxon J; Williams J; Cotton V; Hidalgo A
Biochem Soc Trans; 2009 Jun; 37(Pt 3):589-95. PubMed ID: 19442255
[TBL] [Abstract][Full Text] [Related]
29. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives.
Yehezkel S; Rebibo-Sabbah A; Segev Y; Tzukerman M; Shaked R; Huber I; Gepstein L; Skorecki K; Selig S
Epigenetics; 2011 Jan; 6(1):63-75. PubMed ID: 20861676
[TBL] [Abstract][Full Text] [Related]
30. Telomere maintenance by telomerase and by recombination can coexist in human cells.
Cerone MA; Londono-Vallejo JA; Bacchetti S
Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
[TBL] [Abstract][Full Text] [Related]
31. Telomeres reforged with non-telomeric sequences in mouse embryonic stem cells.
Kim C; Sung S; Kim JS; Lee H; Jung Y; Shin S; Kim E; Seo JJ; Kim J; Kim D; Niida H; Kim VN; Park D; Lee J
Nat Commun; 2021 Feb; 12(1):1097. PubMed ID: 33597549
[TBL] [Abstract][Full Text] [Related]
32. R-Loops at Chromosome Ends: From Formation, Regulation, and Cellular Consequence.
Gong Y; Liu Y
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046839
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic features of human telomeres.
Cubiles MD; Barroso S; Vaquero-Sedas MI; Enguix A; Aguilera A; Vega-Palas MA
Nucleic Acids Res; 2018 Mar; 46(5):2347-2355. PubMed ID: 29361030
[TBL] [Abstract][Full Text] [Related]
35. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
36. TRIM28 inhibits alternative lengthening of telomere phenotypes by protecting SETDB1 from degradation.
Wang C; Songyang Z; Huang Y
Cell Biosci; 2021 Jul; 11(1):149. PubMed ID: 34330324
[TBL] [Abstract][Full Text] [Related]
37. Roles for Histone Acetylation in Regulation of Telomere Elongation and Two-cell State in Mouse ES Cells.
Dan J; Yang J; Liu Y; Xiao A; Liu L
J Cell Physiol; 2015 Oct; 230(10):2337-44. PubMed ID: 25752831
[TBL] [Abstract][Full Text] [Related]
38. Increased TERRA levels and RNase H sensitivity are conserved hallmarks of post-senescent survivors in budding yeast.
Misino S; Bonetti D; Luke-Glaser S; Luke B
Differentiation; 2018; 100():37-45. PubMed ID: 29494831
[TBL] [Abstract][Full Text] [Related]
39. Induced pluripotent stem cells as a model for telomeric abnormalities in ICF type I syndrome.
Sagie S; Ellran E; Katzir H; Shaked R; Yehezkel S; Laevsky I; Ghanayim A; Geiger D; Tzukerman M; Selig S
Hum Mol Genet; 2014 Jul; 23(14):3629-40. PubMed ID: 24549038
[TBL] [Abstract][Full Text] [Related]
40. Characterization and rescue of telomeric abnormalities in ICF syndrome type I fibroblasts.
Yehezkel S; Shaked R; Sagie S; Berkovitz R; Shachar-Bener H; Segev Y; Selig S
Front Oncol; 2013; 3():35. PubMed ID: 23450006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
